Article Versions Notes

Piros ÉA, Szabó Á, Rencz F, Brodszky V, Wikonkál N, Miheller P, Horváth M, Holló P. Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters. Life. 2021; 11(6):535. https://doi.org/10.3390/life11060535

Piros, Éva Anna, Ákos Szabó, Fanni Rencz, Valentin Brodszky, Norbert Wikonkál, Pál Miheller, Miklós Horváth, and Péter Holló. 2021. "Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters" Life 11, no. 6: 535. https://doi.org/10.3390/life11060535

Piros, É. A., Szabó, Á., Rencz, F., Brodszky, V., Wikonkál, N., Miheller, P., Horváth, M., & Holló, P. (2021). Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters. Life, 11(6), 535. https://doi.org/10.3390/life11060535